Why Your Biology Changes After 35 and Why Precision Health is the New Standard
Here is a breakdown of the silent, biological shifts that begin after 35 and why a data-driven, precision health strategy becomes a valuable tool for managing your healthspan.
In your twenties and early thirties, your body tends to forgive a lot: you can push through poor sleep or a bad diet and bounce back quickly. Somewhere around the mid-thirties, that changes. The focus shifts from lifespan (how long you live) to healthspan (how long you live well), as the cumulative effects of lifestyle, genetics and environment begin to show up as real biological change.
Common signs include persistent brain fog, stubborn weight around the middle, achy joints, and energy that predictably crashes in the afternoon. If this sounds familiar, your biology is genuinely changing, and generic advice like "eat less, move more" starts to fall short of addressing it.
IN SHORT
Several biological processes, reduced mitochondrial efficiency, low-grade inflammation and gut microbiome shifts, tend to accelerate from the mid-thirties onward. Testing your own markers shows which of these are relevant to you, rather than relying on generic advice.
The biological shifts behind these changes
Several interconnected processes, the "hallmarks of ageing," begin to accelerate after the mid-thirties [1].
Metabolic decline and mitochondrial dysfunction
Mitochondria become less efficient at producing energy and generate more oxidative stress, a primary driver of fatigue and a slower metabolism. This inefficiency is also associated with age-related muscle loss (sarcopenia), which reduces the body's capacity to store glucose and is linked to insulin resistance over time.
How vivaBALANCE helps: vivaMETABOLITE (urine metabolomics) identifies specific bottlenecks in energy-production pathways and can flag deficiencies in cofactors like CoQ10, B vitamins or L-carnitine that mitochondria need. Your vivaBALANCE plan is personalised around the nutrients your own data indicates you may need.
Chronic low-grade inflammation ("inflammaging")
A persistent, low-level inflammatory state, often originating in the gut, is associated with many age-related conditions, from cardiovascular disease to arthritis [2]. This background inflammation is linked to changes in blood vessel linings over time and to reduced insulin sensitivity.
How vivaBALANCE helps: vivaBIOME (shotgun metagenomic sequencing) identifies specific pro-inflammatory microbes in your gut. Your vivaBALANCE plan is designed to support the growth of anti-inflammatory bacteria relevant to your own results.
The gut-brain and gut-liver connection
An imbalanced gut microbiome can disrupt the "gut-brain axis," reducing production of beneficial compounds like SCFAs and neurotransmitter precursors, which is associated with effects on mood and focus [4, 5]. Reduced SCFA production is also linked to increased gut permeability, allowing more inflammatory compounds into circulation, which research has associated with liver fat accumulation and with broader neuroinflammatory processes.
How vivaBALANCE helps: By analysing the functional potential of your microbiome, vivaBIOME can show whether it's set up to support SCFA production. Your vivaBALANCE plan is designed to help rebuild that capability where it's lacking.
Your "biological age" (epigenetic clock)
Chemical tags on your DNA (like methylation patterns) can drift with age, meaning your biological age can run ahead of your chronological age [11]. This instability in gene expression is an area of active research in relation to long-term cellular health.
How vivaBALANCE helps: this process depends on "methyl donor" nutrients like folate, B12 and choline [12]. vivaMETABOLITE combined with your lifestyle assessment identifies your specific needs for these nutrients, and your plan is built around supporting healthy gene expression accordingly.
Hormonal shifts
After 35, hormone production naturally shifts, including oestrogen in perimenopause and testosterone in men. Your gut microbiome plays a role in metabolising these hormones via the "estrobolome." An imbalanced estrobolome is associated with how oestrogen is processed and excreted, which research has linked to symptom severity during perimenopause [7].
How vivaBALANCE helps: vivaBIOME can identify imbalances in hormone-related gut bacteria. Your vivaBALANCE plan is designed to support these microbes as part of managing symptoms like hot flushes, weight changes and low energy.
Cellular senescence ("zombie cells")
With age, some damaged cells stop dividing but don't die off, instead accumulating and secreting inflammatory compounds that can affect nearby healthy tissue. In joints specifically, this process has been studied in relation to osteoarthritis progression [8].
How vivaBALANCE helps: senolytic compounds that clear these cells are an active area of research. vivaBALANCE's role is more foundational: using your test data to help reduce the systemic inflammation and oxidative stress that are associated with cells becoming senescent in the first place.
Proteostasis (protein management)
The body's ability to manage and clear misfolded or damaged proteins declines with age. Protein aggregation is studied extensively in relation to neurodegenerative conditions [9].
How vivaBALANCE helps: protein recycling (autophagy) is energy-intensive. vivaMETABOLITE data can help optimise mitochondrial function and ensure adequate amino acid availability, supporting this process as part of your broader plan.
Why generic advice falls short after 35
Generic advice, like taking CoQ10 for energy, turmeric for inflammation, or a popular probiotic for gut health, is a reasonable starting point but doesn't answer the specific questions that matter for you: is your fatigue actually caused by low CoQ10, or by an inflammatory gut microbe affecting your mitochondria? Does your probiotic contain the strains you personally need? After 35, your biology is specific enough that this kind of guesswork becomes inefficient.
Testing instead of guessing
The vivaBALANCE protocol measures your metabolic function (vivaMETABOLITE) and gut microbiome (vivaBIOME) in the context of your lifestyle. vivaOS, vivaLAB's AI health intelligence platform, brings these data points together into a plan aimed at the specific biological patterns showing up in your own results, rather than generic averages.
Understand what's actually changing in your biology
A vivaINSIGHT test combines vivaBIOME and vivaMETABOLITE to show your inflammation, metabolic and gut markers. vivaBALANCE 360 retests at 4 and 9 months to track how they change.
vivaLAB's services are designed to support health optimisation and are not a substitute for medical advice. Consult a qualified health practitioner for individual health decisions, including any concerns about the specific conditions mentioned above.
References:
- López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The hallmarks of aging. Cell, 153(6), 1194–1217. PMID: 23746838.
- Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018). Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 14(10), 576–590.
- Thevaranjan, N., Puchta, A., Schulz, C., et al. (2017). Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction. Cell Host & Microbe, 21(4), 455–466.
- Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., et al. (2019). The Microbiota-Gut-Brain Axis. Physiological Reviews, 99(4), 1877–2013.
- Parada Venegas, D., De la Fuente, M. K., Landskron, G., et al. (2019). Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Frontiers in Immunology, 10, 277. PMID: 30915065.
- Jones, P. A., & Baylin, S. B. (2007). The epigenomics of cancer. Cell, 128(4), 683–692.
- Baker, J. M., Al-Nakkash, L., & Herbst-Kralovetz, M. M. (2017). Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas, 103, 45–53. PMID: 28778332.
- Jeon, O. H., Kim, C., Laberge, R. M., et al. (2017). Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis. Nature Medicine, 23(6), 775–781.
- Labbadia, J., & Morimoto, R. I. (2015). The biology of proteostasis in aging and disease. Annual Review of Biochemistry, 84, 435–464.
- Ranjan, R., Rani, A., Metwally, A., McGee, H. S., & Perkins, D. L. (2016). Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochemical and Biophysical Research Communications, 469(4), 967–977. PMID: 26718401.
- Horvath, S., & Raj, K. (2018). DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nature Reviews Genetics, 19(6), 371–384.
- Ordovas, J. M., & Corella, D. (2004). Nutritional genomics. Annual Review of Genomics and Human Genetics, 5, 71–118. PMID: 15485344.
Don't Miss Out on the Latest Insights
Sign up to our newsletter and stay in the loop with practical advice and discoveries in gut health, personalised wellness, and microbiome science.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. By submitting, I agree to vivaLAB Privacy Policy. You can unsubscribe at any time.
You Might Also Like
Keep reading and discover more stories, tips, and insights that complement what you've just explored.
The supplement powder category is a multi-billion dollar industry built on a single powerful idea: that you can compress the nutritional complexity of a healthy life into one daily scoop.
Our organs age at different rates and not necessarily in line with our chronological age which is referred to as Biological Drift. We can map the drift via multi-omics testing, ultimately forecast it to help improve our healthspan.
Dr Pennie Taylor dives into what's really happening in women's bodies during perimenopause and menopause and how to thrive through The Change.